What were Biocon Ltd's latest quarterly results?
Biocon Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: -56.6%
- Revenue Growth YoY: +2.3%
- Operating Margin: 23.0%
Biocon Ltd: Stock Analysis & Fundamentals
Updated this weekBiocon Ltd (Pharma - Formulators) — fundamental analysis, earnings data, and key metrics. PE: 175.0. ROE: 1.4%. This stock is not currently in the Nifty 500 momentum outperformers list.
Biocon Ltd Key Facts
What's Happening
👔Promoter stake down 6.2% this quarter
🌐FII stake increased 0.7% this quarter
🏛️DII accumulation — stake up 7.6%
Key Numbers
Current Price
₹421
Dividend Yield
0.12%
Market Cap
68.2K Cr
Valuation
N/AOther Top Pharma - Formulators Stocks Beating Nifty 500
Frequently Asked Questions: Biocon Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Biocon Ltd's current PE ratio?
Biocon Ltd's current PE ratio is 175.0x.
- Current PE: 175.0x
- Market Cap: 68.2K Cr
- Dividend Yield: 0.12%
What is Biocon Ltd's price-to-book ratio?
Biocon Ltd's price-to-book ratio is 2.0x.
- Price-to-Book (P/B): 2.0x
- Book Value per Share: ₹210
- Current Price: ₹421
Is Biocon Ltd a fundamentally strong company?
Biocon Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 4.0%
Is Biocon Ltd debt free?
Biocon Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹15,000 Cr
What is Biocon Ltd's return on equity (ROE) and ROCE?
Biocon Ltd's return ratios over recent years
- FY2024: ROCE 6.0%
- FY2025: ROCE 6.0%
- FY2026: ROCE 4.0%
Is Biocon Ltd's cash flow positive?
Biocon Ltd's operating cash flow is positive (FY2026).
- Cash from Operations (CFO): ₹2,000 Cr
- Free Cash Flow (FCF): ₹-88 Cr
- CFO/PAT Ratio: 540% (strong cash conversion)
What is Biocon Ltd's dividend yield?
Biocon Ltd's current dividend yield is 0.12%.
- Dividend Yield: 0.12%
- Current Price: ₹421
Who holds Biocon Ltd shares — promoters, FII, DII?
Biocon Ltd's shareholding pattern (Mar 2026)
- Promoters: 44.9%
- FII (Foreign): 7.5%
- DII (Domestic): 24.0%
- Public: 23.4%
Is promoter holding increasing or decreasing in Biocon Ltd?
Biocon Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 44.9% (Mar 2026)
- Previous Quarter: 44.9% (Jan 2026)
- Change: 0.00% (stable)
Is Biocon Ltd a new momentum entry or an established outperformer?
Biocon Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Biocon Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Biocon Ltd may be worth studying
- Cash flow is positive — CFO ₹2,000 Cr
What is the investment thesis for Biocon Ltd?
Biocon Ltd investment thesis summary:
What is the future outlook for Biocon Ltd?
Biocon Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.